SAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Avantor, Inc. (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025. Avantor provides scientific products and services for customers in biotechnology, pharmaceuticals, healthcare, education, government, and other industries. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350- ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Unicycive (UNCY) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Unicycive between March 29, 2024 and June 27, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Braga ...

Accessibility StatementSkip Navigation Attorney Advertising.  Past results do not guarantee a similar outcome.  SAN DIEGO, Oct. 29, 2025 /PRNewswire/ -- Company: Fortinet, Inc. (NASDAQ: FTNT) is a cyber security company. Class Period: November 8, 2024 – August 6, 2025 The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Fortinet, Inc. because the Company misrepresented the impact of unit upgrades for FortiGate Fir ...

公司概况 - 公司为Marex Group PLC 是一家总部位于英国、业务多元化的全球金融服务平台 [1] 法律诉讼核心 - 针对Marex Group PLC的集体诉讼已提起 代表在2024年8月14日至2025年8月5日期间卖空该公司证券的所有个人和实体 [2] - 诉讼指控公司就其收入预测误导了投资者 [2] 具体指控内容 - 指控称 被告未能告知投资者 其通过表外关联方交易不当夸大了现金流以及其做市部门的收入、资产和利润 [3] - 据称 此类不当行为导致集体成员遭受重大损失和损害 [3] 诉讼后续步骤 - 股东可能有资格参与针对Marex Group PLC的集体诉讼 [4] - 希望担任集体诉讼首席原告的股东必须在2025年12月8日前向法院提交文件 [4]

SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Company: MoonLake is a Swiss clinical-stage biotechnology company focused on inflammatory diseases driven by interleukin-17 (IL-17), particularly in dermatology and rheumatology. Class Period: March 10, 2024 - September 29, 2025 The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired MoonLake Immunotherapeutics common stock because the Company allegedly misled investors regarding the ...

SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Company: Quanex is an international supplier of engineered home components and access solutions to the construction industry, including windows, doors, cabinetry, and vinyl products. Class Period: December 12, 2024 - September 5, 2025 The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Quanex Building Products Corporation (NYSE: NX) because the Company allegedly failed to ...

诉讼核心 - 集体诉讼代表在2025年5月6日至2025年6月19日期间购买KBR公司证券的投资者提起[1] - 诉讼指控KBR就合资公司HomeSafe Alliance履行TRANSCOM合同的能力误导投资者[1][3] 涉事合资公司与合同 - HomeSafe Alliance是KBR拥有72%经济利益的合资公司[2] - 在集体诉讼期开始前，HomeSafe获得了美国国防部运输司令部（TRANSCOM）的全球家居用品运输合同[2] 指控详情 - 原告指控被告在集体诉讼期间已知晓TRANSCOM对HomeSafe履行合同能力存在重大担忧数月之久[3] - 但被告声称合作没有问题，并将在未来几个季度加速推进[3] 事件披露与市场影响 - 2025年6月19日，HomeSafe发布新闻稿，披露TRANSCOM已发出终止合同的通知，并揭示双方存在问题已持续数月[4] - 次日KBR发布公告确认合同终止，导致KBR股价在2025年6月20日下跌3.85美元，跌幅7.29%，收于48.93美元[4] - 下一个交易日（2025年6月23日），KBR股价进一步下跌1.30美元，跌幅2.65%，收于47.63美元[4]

SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Company: Fluor provides engineering, procurement, and construction (“EPC”), fabrication and modularization, and project management services worldwide. Class Period: February 28, 2025 - July 31, 2025 The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Fluor Corporation (NYSE: FLR) securities because the Company allegedly misled investors about its business prospects. For m ...

SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Company: Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. Class Period: December 27, 2023 - May 6, 2025 The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Cyto ...

SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Company: Jasper, a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (“CSU”), Chronic Inducible Urticaria (“CIndU”), and Asthma. Class Period: November 30, 2023 - July 3, 2025 The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Jasper Therapeutics, Inc. (NASDAQ: JSPR) because t ...